VOICED : Justicia de EEUU aprueba disolver firma que fue eje de la crisis de los opioides

VOICED : Justicia de EEUU aprueba disolver firma que fue eje de la crisis de los opioides

Assessment

Interactive Video

Business, Social Studies, History

10th - 12th Grade

Hard

Created by

Quizizz Content

FREE Resource

A U.S. federal judge approved a plan to dissolve Purdue Pharma, the maker of Oxycontin, linked to the opioid crisis. The Sackler family, owners of Purdue, will pay $4.5 billion but avoid further penalties. Purdue admitted to criminal charges for promoting the addictive drug, which led to over 500,000 overdose deaths in the U.S. over 20 years. The company will be sold in 2024 and replaced by a new entity focused on safe opioid promotion. The agreement also allocates billions to organizations addressing addiction crisis consequences.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What was the outcome for the Sackler family in the Purdue Pharma dissolution plan?

They were fined $10 billion.

They were forced to sell all their assets.

They were sentenced to prison.

They were protected from further penalties.

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What was Purdue Pharma found guilty of?

Bribing government officials.

Manufacturing faulty products.

Aggressively promoting an addictive drug.

Evading taxes.

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How many overdose deaths have been attributed to the opioid crisis in the last 20 years?

Over 250,000

Over 100,000

Over 1 million

Over 500,000

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the plan for Purdue Pharma in 2024?

It will be sold and replaced by a new entity.

It will continue under the same management.

It will merge with another company.

It will be dissolved completely.

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What will the new entity replacing Purdue Pharma focus on?

Expanding opioid production.

Reducing costs by cutting staff.

Restricting opioid promotion and ensuring safety.

Increasing profits through new drugs.